Skip to content

FORM 53.002A

Reporting of fraud in clinical trials of an investigational medicinal product not identified as a serious breach of GCP

FORM 52.015D

Phase I or High Risk Committees Combined Review

FORM 52.015C

Phase I and High Risk Reviewers comments

FORM 52.015A

Categorisation of Phase I (FIH) Trial